In the 50 years since the first successful human bone marrow transplant (BMT) was performed in 1959, BMT has become the optimal therapy for a wide variety of life-threatening paediatric haematological, immunological and genetic disorders. Unfortunately, while BMT generally provides the only possibility of cure for such afflicted children, few (25%) have a matched sibling available, and suitably matched unrelated donors are often not identified for many children in need of BMT. And even where BMT is possible, treatment is complex and arduous and associated with significant mortality and morbidity. The issues raised when either or both the donor and recipient are children and lack the capacity to make informed and rational decisions relating ...
Allogenic haematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for...
Over the past decade, relevant improvements and refinements have significantly changed the indicatio...
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for ...
The two most widely used sources of hematopoietic stem cells for allogeneic transplants in pediatric...
The two most widely used sources of hematopoietic stem cells for allogeneic transplants in pediatric...
AbstractRelated donors for hematopoietic cell (HC) transplantation are a growing population in recen...
At the end of 1999 the Danish Council of Ethics published a report on organ and tissue donation from...
This open access book offers insights in short- and long-term experiences from families with bone ma...
Irreversible severe bone marrow failure (BMF) is a life-threatening condition in pediatric patients....
To evaluate the role of allogeneic bone marrow transplantation (BMT) in children with chronic myelom...
Hematopoietic stem cell transplantation (HSCT) is an important treatment option for children with se...
A multicenter cooperative group has been activated in Italy in 1986, with the aim of focusing on the...
Background and Objectives. Transplantation of hematopoietic stem cells from different sources is bei...
BACKGROUND AND OBJECTIVE: Transplantation of hematopoietic stem cells from different sources is bein...
AbstractBone marrow failure (BMF) syndromes include a broad group of diseases of varying etiologies,...
Allogenic haematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for...
Over the past decade, relevant improvements and refinements have significantly changed the indicatio...
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for ...
The two most widely used sources of hematopoietic stem cells for allogeneic transplants in pediatric...
The two most widely used sources of hematopoietic stem cells for allogeneic transplants in pediatric...
AbstractRelated donors for hematopoietic cell (HC) transplantation are a growing population in recen...
At the end of 1999 the Danish Council of Ethics published a report on organ and tissue donation from...
This open access book offers insights in short- and long-term experiences from families with bone ma...
Irreversible severe bone marrow failure (BMF) is a life-threatening condition in pediatric patients....
To evaluate the role of allogeneic bone marrow transplantation (BMT) in children with chronic myelom...
Hematopoietic stem cell transplantation (HSCT) is an important treatment option for children with se...
A multicenter cooperative group has been activated in Italy in 1986, with the aim of focusing on the...
Background and Objectives. Transplantation of hematopoietic stem cells from different sources is bei...
BACKGROUND AND OBJECTIVE: Transplantation of hematopoietic stem cells from different sources is bein...
AbstractBone marrow failure (BMF) syndromes include a broad group of diseases of varying etiologies,...
Allogenic haematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for...
Over the past decade, relevant improvements and refinements have significantly changed the indicatio...
Allogenic hematopoietic progenitor cell transplantation (allo-HSCT) is an established treatment for ...